All Stories

  1. Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas
  2. Molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer
  3. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection
  4. Recent advances in understanding Epstein-Barr virus
  5. Viruses and the DNA Damage Response: Activation and Antagonism
  6. Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest
  7. Dynamic Epstein–Barr Virus Gene Expression on the Path to B-Cell Transformation
  8. Heavy LIFting: tumor promotion and radioresistance in NPC
  9. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis
  10. Epstein-Barr Virus Induces Global Changes in Cellular mRNA Isoform Usage That Are Important for the Maintenance of Latency
  11. Interplay Between DNA Tumor Viruses and the Host DNA Damage Response
  12. Use of Viral Systems to Study miRNA-Mediated Regulation of Gene Expression in Human Cells
  13. The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
  14. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation
  15. Structure of Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor Nectin-1
  16. At a crossroads: human DNA tumor viruses and the host DNA damage response
  17. An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells
  18. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41
  19. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody
  20. Glycoprotein B of Human Herpesvirus 8 Is a Component of the Virion in a Cleaved Form Composed of Amino- and Carboxyl-Terminal Fragments